Shenzhen New Industries Biomedical Engineering Co., Ltd.

XSEC:300832 Stock Report

Market Cap: CN¥49.9b

Shenzhen New Industries Biomedical Engineering Future Growth

Future criteria checks 5/6

Shenzhen New Industries Biomedical Engineering is forecast to grow earnings and revenue by 22.1% and 21.5% per annum respectively. EPS is expected to grow by 22% per annum. Return on equity is forecast to be 24.1% in 3 years.

Key information

22.1%

Earnings growth rate

22.0%

EPS growth rate

Medical Equipment earnings growth26.4%
Revenue growth rate21.5%
Future return on equity24.1%
Analyst coverage

Good

Last updated18 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:300832 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20267,1353,0162,3412,87615
12/31/20255,8312,4491,8822,28616
12/31/20244,7361,9781,4622,07215
9/30/20244,4361,8511,0641,449N/A
6/30/20244,2751,8071,1611,510N/A
3/31/20244,0751,7251,1311,500N/A
12/31/20233,9301,6541,0961,418N/A
9/30/20233,6581,5907971,222N/A
6/30/20233,4951,5086111,051N/A
3/31/20233,1801,375535961N/A
1/1/20233,0471,328543962N/A
9/30/20222,9481,233633990N/A
6/30/20222,7371,115572931N/A
3/31/20222,7561,114464835N/A
1/1/20222,545974430773N/A
9/30/20212,518906420733N/A
6/30/20212,451892516832N/A
3/31/20212,4399978091,069N/A
12/31/20202,195939722977N/A
9/30/20202,0659117641,009N/A
6/30/20201,911910742960N/A
3/31/20201,655745462754N/A
12/31/20191,682773505832N/A
12/31/20181,384694417702N/A
12/31/20171,141538N/A525N/A
12/31/2016923452N/A487N/A
9/30/2016867380N/A438N/A
6/30/2016811307N/A389N/A
3/31/2016771278N/A348N/A
12/31/2015732249N/A306N/A
9/30/2015677264N/A278N/A
6/30/2015623279N/A250N/A
3/31/2015584266N/A246N/A
12/31/2014545253N/A243N/A
9/30/2014506224N/A213N/A
6/30/2014467194N/A182N/A
3/31/2014423168N/A160N/A
12/31/2013378141N/A138N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300832's forecast earnings growth (22.1% per year) is above the savings rate (2.8%).

Earnings vs Market: 300832's earnings (22.1% per year) are forecast to grow slower than the CN market (26.2% per year).

High Growth Earnings: 300832's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300832's revenue (21.5% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 300832's revenue (21.5% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300832's Return on Equity is forecast to be high in 3 years time (24.1%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y